In a retrospective study of 119 patients, followed for 1 to 30 years after treatment of a papillary carcinoma of the thyroid, the authors searched for possible prognostic factors of the risk of recurrence. Microcarcinomas, anaplastic tumors and HΓΌrthle cell carcinomas were excluded from the study. I
CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells
β Scribed by Lei Cui; Qing Zhang; Zhengfa Mao; Jixiang Chen; Xuqing Wang; Jianguo Qu; Jianxin Zhang; Dayong Jin
- Book ID
- 107693934
- Publisher
- S. Karger AG
- Year
- 2011
- Tongue
- English
- Weight
- 407 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1010-4283
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background To determine the prognostic value of thyroid suppression therapy in patients with thyroid carcinoma, we studied the effect of thyroidβstimulating hormone (TSH) on the morphology, proliferation rate, and the T3, T4 production rate of primary thyroid carcinoma cells in cult
## Abstract ## Objectives/Hypothesis: We analyzed the expression of urokinase plasminogen activator (uPA) and its receptor (uPAR) in papillary thyroid carcinoma (PTC) and normal thyroid tissue and examined in vitro how uPA and uPAR contribute to an invasive/metastatic phenotype, and the functional